Lung Cancer

Disease State Hub

Q&As

Hypertension

Blánaid Hicks, PhD, BSc, on BP Medications and Lung Cancer Risk

11/13/2018

Consultant360 spoke with Blánaid Hicks, PhD, BSc, from Queen’s University Belfast, whose study found that the use of angiotensin converting enzyme inhibitors may be tied to an increased lung cancer risk...

11/13/2018

Research Summaries

Conference Coverage

Case-based Approaches to Diagnostic Radiology

04/26/2023

Anthony Calabro, MA

In their presentation at the 48th ONS Congress, in San Antonio, Texas, Kathy Waitman DNP, APN-BC, AOCNP and Shaunna Kersten CNS, MSN, ANP identified the best imaging modalities based on common oncologic...

04/26/2023

Metastatic Lung Cancer

FDA Approves Tremelimumab in Combination With Additional Medication for Metastatic Non-Small Cell Lung Cancer

12/07/2022

The FDA-approved treatment combines tremelimumab, durvalumab, and platinum-based chemotherapy, and follows a randomized trial.

12/07/2022

Screening

New USPSTF Lung Cancer Screening Guidelines Improve Representation of Black Patients

06/30/2022

In a new study, investigators examined the impact of the expanded lung cancer screening criteria on the mortality rate of high-risk patient populations.

06/30/2022

Lung Cancer Screening

CHEST Updates Lung Cancer Screening Guidelines

07/15/2021

The American College of Chest Physicians has released new guidelines on screening patients for lung cancer after a review of current literature was performed.

07/15/2021

Lung Cancer Screening

USPSTF Expands Lung Cancer Screening Recommendations

03/10/2021

The US Preventive Services Task Force has updated its recommendations on who and when to screen for lung cancer.

03/10/2021

October 2024

Current Issue

October 2024

Volume 64

Issue 9